The experts of PASREL-imagerie, located on the Saclay plateau in the Paris region, advise you during all phases of design, planning, execution and validation of drug development protocols:
IDMIT (Infectious Diseases Models for Innovative Therapies) is specialized in the field of human infectious diseases and autoimmune diseases (AIDS, hepatitis B, seasonal and pandemic influenza, SARS, chikungunya, malaria, chlamydia, tuberculosis, etc.). This department is dedicated to preclinical research through the development of animal models. IDMIT houses the Imaging of Infection and Immunity Laboratory (L3i) which has the following equipment:
Dedicated to translational research on neurodegenerative diseases and retinal pathologies (Vision Institute partnership), MIRCen (Molecular Imaging Research Center) has internationally recognized expertise in gene therapy, as well as in molecular neuroimaging by PET and MRI. MIRCen teams are working on the development of animal models of human neurological pathologies (Parkinson's, Huntington's, Alzheimer's and related diseases) or ophthalmic diseases.
Once characterized, these models are used for diagnostic innovation (early diagnosis of abnormalities in the early stages of the disease) and/or for the evaluation of innovative therapies (gene therapy, cell therapy, interventional surgery, drug approaches) in the field of neurodegenerative diseases. MIRCen has the following imaging equipment:
NeuroSpin is a research infrastructure dedicated to brain neuroimaging using high-field MRI. This platform, unique in Europe, offers exceptional resources to the scientific community. It has the following imaging equipment:
These technical platforms are completed by the CATI, a national image processing platform dedicated to multicenter neuroimaging studies.
Dedicated to multimodal PET, MRI and ultrasound imaging, the SHFJ (Service Hospitalier Frédéric Joliot) provides both a diagnostic activity (nuclear medicine unit) and a research activity through the UMR BioMaps created in early 2020. The SHFJ has the following cameras/imagers dedicated to research:
The SHFJ is also equipped with an experimental radiopharmaceutical manufacturing platform for EU/GMP clinical PET imaging (cyclotron/radiochemistry) adapted to "phase 0" trials (microdose).
PASREL-imagerie experts have developed experience in pharmaceutical R&D, instrument engineering and signal processing. They have contributed to major advances in the discipline in various research fields, notably infectious diseases, neurodegenerative diseases, oncology, ophthalmology, childhood brain pathologies, and psychiatry.
PASREL-imagerie provides you with translational approaches ranging from the validation of biomarkers to the efficacy of drug candidates with biodistribution studies, the characterization of the pathophysiology of diseases to early clinical trials.
The in vivo imaging approaches are associated to state-of-the-art platforms such as animal models of several diseases, motor and cognitive behavior studies, biotherapies, genomics, flow and mass cytometry, viral vector production, ex vivo imaging, etc.